We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma

    Background

    Esophageal squamous cell carcinoma (ESCC) is a highly prevalent and aggressive cancer with poor treatment outcomes. Despite the critical...

    Shan Huang, Jiayi Zhang, ... Yuting Yang in Journal of Translational Medicine
    Article Open access 11 June 2023
  2. Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

    Background

    Immune checkpoint inhibitors prolong the survival of non-small cell lung cancer (NSCLC) patients. Although it has been acknowledged that...

    Toshihiko Kaneda, Takayasu Kurata, ... Koji Tsuta in BMC Cancer
    Article Open access 08 February 2022
  3. Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets

    The onerous health and economic burden associated with head and neck squamous cell carcinoma (HNSCC) is a global predicament. Despite the advent of...

    Mengchen Xu, Yiming Hou, ... Lei Chen in Journal of Translational Medicine
    Article Open access 03 May 2024
  4. Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes

    Background

    The WNT signal pathway has myriad family members, which are broadly involved in embryonic development and human cancer. Over-activation of...

    Cheng Chen, Lunan Luo, ... **g Yang in BMC Cancer
    Article Open access 19 July 2022
  5. The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy

    The development of head and neck squamous cell carcinoma (HNSCC) is a multi-step process, and its survival depends on a complex tumor ecosystem,...

    Yingying Gong, Lisha Bao, ... Minghua Ge in Molecular Cancer
    Article Open access 06 April 2023
  6. Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma

    Background

    Research studies have demonstrated that Midkine (MDK) can influence the expression and activity of Renin-angiotensin system (RAS)...

    Tai-Jan Chiu, Chang-Han Chen, ... Sheng‑Dean Luo in Cancer Cell International
    Article Open access 24 September 2023
  7. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma

    Background

    Cancer stemness has been proven to affect tumorigenesis, metastasis, and drug resistance in various cancers, including lung squamous cell...

    **zhi Lai, **nyi Lin, ... Deqiang Fu in BMC Cancer
    Article Open access 08 June 2023
  8. A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma

    Background

    IgG4, which plays a pivotal role in the progression of phenotypically diverse tumors, serves as a prognostic marker because of its...

    Hironobu Fukuda, Takeshi Uehara, ... Hiroshi Kurita in BMC Cancer
    Article Open access 04 March 2024
  9. miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39

    Exosomes are emerging mediators of cell-cell communication, which are secreted from cells and may be delivered into recipient cells in cell...

    Lu Wang, Huijuan Liu, ... **aolong Cheng in Cancer Gene Therapy
    Article 22 April 2024
  10. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance

    Background

    Immune checkpoint blockade (ICB) therapy has revolutionized the treatment of lung squamous cell carcinoma (LUSC). However, a significant...

    Minglei Yang, Chenghao Lin, ... Weizhong Li in Genome Medicine
    Article Open access 08 July 2022
  11. ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles

    Background

    Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with no clinically ideal biomarkers for early diagnosis. The objective of this...

    Tiandong Li, Guiying Sun, ... Peng Wang in British Journal of Cancer
    Article 02 July 2024
  12. Switched alternative splicing events as attractive features in lung squamous cell carcinoma

    Background

    Alternative splicing (AS) plays important roles in transcriptome and proteome diversity. Its dysregulation has a close affiliation with...

    Boxue He, Cong Wei, ... **ang Wang in Cancer Cell International
    Article Open access 05 January 2022
  13. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma

    Background

    A growing body of evidence suggests that pyroptosis-related lncRNAs (PRncRNAs) are associated with the prognoses of tumor patients and...

    Wei Zhou, Wenxiong Zhang in BMC Cancer
    Article Open access 23 June 2022
  14. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma

    Background

    The role of the PRDM5 in esophageal squamous cell carcinoma (ESCC) has not been revealed. This study investigated the relationship between...

    **g Guo, Qiuxing Yang, ... Gaoren Wang in BMC Cancer
    Article Open access 07 July 2022
  15. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1

    Background

    USP51 is a deubiquitinase (DUB), that is involved in diverse cellular processes. Accumulating evidence has demonstrated that USP51...

    ** Chen, Zhongqiu Wu, ... Wenting Li in Journal of Translational Medicine
    Article Open access 08 July 2023
  16. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma

    The polycomb group (PcG) comprises a set of proteins that exert epigenetic regulatory effects and play crucial roles in diverse biological processes,...

    Yuxi Cheng, Zhengzheng Song, ... Zhangui Tang in Clinical Epigenetics
    Article Open access 10 April 2024
  17. Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma

    Background

    Cancer cells promote glycolysis, which supports rapid cell growth and proliferation. Phosphofructokinase-fructose bisphosphatases (PFKFBs),...

    Kai-Fang Hu, Chih-Wen Shu, ... Pei-Feng Liu in Cancer Cell International
    Article Open access 02 November 2023
  18. Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers

    Antibody-drug conjugates (ADCs) are an emerging class of therapeutics for lung cancer, and several are currently in development for this malignancy....

    Laura Bender Somme, Christos Chouaid, ... Roland Schott in BioDrugs
    Article Open access 20 May 2024
  19. Autophagy and nuclear morphometry are associated with histopathologic features in esophageal squamous cell carcinoma

    Abstract

    Less than 15% of patients with esophageal squamous cell carcinoma (ESCC) survive 5 years after diagnosis. A better understanding of the...

    Ricardo Iserhard, Emily Ferreira Salles Pilar, ... Eduardo Cremonese Filippi-Chiela in Journal of Molecular Medicine
    Article 25 October 2023
  20. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma

    Accumulating evidence indicates that the disulfiram/copper complex (DSF/Cu) has been shown to have potent antitumor activity against various cancers....

    Yanjuan Zhao, Shu** Zhu in Biochemical Genetics
    Article 08 June 2023
Did you find what you were looking for? Share feedback.